RGT 0.00% 30.0¢ argent biopharma limited

Ann: Retraction of Statement, page-4

  1. 1,873 Posts.
    lightbulb Created with Sketch. 952
    The Company wishes to retract statements regarding assumed penetration rates, estimated market share and theoretical sales potential across the UK and Europe.

    >>>>>>To be clear, the company should quote and retract the statements concerned. They should, then re-issue the amended “Non-deal roadshow”.


    The Company advises that it does not have reasonable basis for making these forward-looking statements and investors should not rely on the retracted information as a basis for an investment decision..

    >>>>>>.i.e. the company purposely mislead (lied to) investors.
    It’s gratifying that someone pulled up these carpetbaggers in an attempt to curb their criminality.
    There is still no confirmation of the actual existence of the facility in Malta, let alone that it has GMP certification!

    So why the “Non-deal roadshow”?

    Non-deal roadshows (NDRs) offer investors a comprehensive look at a company's story that press releases, conference presentations, and other public documents cannot. Public and private companies alike may benefit from scheduling NDRs to foster effective communication between the executive team and investors. (Google).

    If they want to ‘foster effective communication’, the least they can do is, tell the truth.

    Desperate measures in desperate times……………….. desperate to stop this terminal company from sinking into the abyss.

 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.000(0.00%)
Mkt cap ! $13.58M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 2500 26.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 3022 4
View Market Depth
Last trade - 16.12pm 28/06/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.